Table 3 Self-reported factors negatively affecting the patient’s ability of taking medication at home as prescribed during COVID-19 lockdown (N = 171)

Overall

89 (52.1)

61 (35.7)

42 (24.6)

27 (15.8)

22 (12.9)

Clinical program

(p = 0.920)

(p = 0.487)

(p = 0.022)

(p = 0.080)

(p = 0.232)

 HIV/AIDS

25 (51.0)

18 (36.7)

6 (12.2)

14 (28.6)

9 (18.4)

 Non-communicable diseases

26 (54.2)

20 (41.7)

11 (22.9)

4 (8.3)

3 (6.3)

 Mental health

22 (51.2)

15 (34.9)

13 (30.2)

5 (11.6)

7 (16.3)

 Pediatric Development Clinic

3 (75.0)

2 (50.0)

3 (75.0)

0 (0.0)

1 (25.0)

 Oncology

13 (48.2)

6 (22.2)

9 (33.3)

4 (14.8)

2 (7.4)

Estimated time (hours) from home to the health facility of usual health care

(p = 0.317)

(p = 0.482)

(p = 0.557)

(p = 0.891)

(p = 0.549)

  < 1 h

24 (43.6)

16 (29.1)

13 (23.6)

8 (14.6)

6 (10.9)

 1–2 h

45 (55.6)

31 (38.3)

18 (22.2)

14 (17.3)

13 (16.1)

  > 2 h

20 (57.1)

14 (40.0)

11 (31.4)

5 (14.3)

3 (8.6)

District of residence

(p < 0.001)

(p < 0.001)

(p < 0.001)

(p < 0.001)

(p = 0.002)

 Kayonza

15 (27.8)

6 (11.1)

7 (13.0)

1 (1.9)

3 (5.6)

 Kirehe

45 (77.6)

35 (60.3)

26 (44.8)

18 (31.0)

15 (25.9)

 Burera

29 (49.2)

20 (33.9)

9 (15.3)

8 (13.6)

4 (6.8)

Socio-economic status (Ubudehe category)^a

(p = 0.863)

(p = 0.892)

(p = 0.613)

(p = 0.485)

(p = 0.324)

 1

17 (53.1)

12 (37.5)

7 (21.9)

3 (9.4)

3 (9.4)

 2

34 (54.0)

23 (36.5)

13 (20.6)

12 (19.1)

11 (17.5)

 3

37 (49.3)

25 (33.3)

21 (28.0)

11 (14.7)

7 (9.3)

Living with someone who could help remind the patient to take medication or accompany the patient to the health facility^b

(p = 0.598)

(p > 0.999)

(p = 0.288)

(p = 0.336)

(p = 0.440)

 No

24 (55.8)

15 (34.9)

12 (27.9)

9 (20.9)

7 (16.3)

 Yes

64 (50.4)

46 (36.2)

29 (22.8)

18 (14.2)

15 (11.8)